Results 261 to 270 of about 67,119 (304)

Biological Drivers of IMiD‐Induced Peripheral Neuropathy in Multiple Myeloma

open access: yeseJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT The introduction of immunomodulatory drugs (IMiDs), such as thalidomide, lenalidomide and pomalidomide, have led to significant improvements in multiple myeloma (MM) treatment. Many patients now live 10 years or longer with their disease, making treatment‐related side effects increasingly important.
Sina A. Beer   +2 more
wiley   +1 more source

Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous Nephropathy. [PDF]

open access: yesKidney Int Rep
Cheddadi Y   +6 more
europepmc   +1 more source

Perioperative immune dynamics during cardiopulmonary bypass and association with major adverse postoperative events. [PDF]

open access: yesFront Cardiovasc Med
Cheng Z   +9 more
europepmc   +1 more source

Evaluating the utility of a nanoscale flow cytometer for detection of surface proteins on HIV and extracellular vesicles. [PDF]

open access: yesVirol J
Burnie J   +7 more
europepmc   +1 more source

Plenary Abstracts Session & Oral Presentations

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy